The quarantine authorities announced on the 14th that "Domestic antibody treatments showed an effect on the mutations of corona infections originating in Nigeria, the United Kingdom," over the fact that the Celltrion corona treatment, which the government has provided intensively, is ineffective against mutations in South Africa and Brazil.
Joon-wook Kwon, deputy head of the company's junior high school department, said at a regular briefing that day, "there was no effect on the South African mutation, and the neutralizing ability was significantly reduced in the Brazilian mutation." I confirmed that there is,” he announced as'Effective Check'.
"When tested at the cell line level, (Rekironaga) showed little effect on the existing South African mutant. Compared to that, the Brazilian mutant showed more than twice the efficacy, but (neutralizing ability) significantly decreased." "California, New York , The Nigerian mutant showed 5 to 10 times higher neutralizing ability than the British mutant, although it was less effective than the British mutant." 'Efficacy'.
The quarantine authorities said on the day that Celltrion's Rekirona has been administered to 3026 patients in 75 hospitals, and Gilead's Remdesivir has been administered to 6825 patients in 125 hospitals.
The quarantine authorities announced in February 2 that the South African mutant was found to be incapacitated, and the medical community pointed out the side effects of the mutant administration, postponing it to a'decision of the doctor' and advocating the administration.
Former Chairman Seo Jeong-jin of Celltrion told the Hankyoreh, ``It will become a corona-clean country next spring,'' revealing the completion of production of 100,000 Rekkirona in December last year.
Kang-lip Kim, head of the Ministry of Food and Drug Safety, who led the support for Celltrion treatment, held a domestic vaccine development support conference held at Millinium Hilton on the 13th and encouraged corporate officials
Newsis announced on that day with the title of , and JoongAng Ilbo In each report under the title,'South African and Brazilian mutant armed forces' were excluded.
Germany designated Britain and Northern Ireland as 'low-risk areas' on the 14th for the Indian mutation, and British Prime Minister Johnson said on the previous day that "we are concerned about the spread of mutations from India" in the UK, but the Korean script was Celltrion Rekirona, The results of Rekirona's Indian mutation were not published.
The BBC reported on the 15th that the Indian variant has 50% more transmission power than the UK variant.